Nutrient deficit common in type 2 diabetes patients A review of data spanning 25 years found 45% of patients had multiple micronutrient deficiencies, with women more likely than men to be impacted.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
World experts urge overhaul of obesity definition The Global Commission on Clinical Obesity says diagnosis must change, setting out new criteria, categories, and calling on doctors to go ‘beyond BMI’.
Australia’s new leading contributor to burden of disease Smoking tobacco has been overtaken by overweight and obesity as the leading modifiable risk factor, according to a new report.
Gabapentinoids may increase hip fractures: Study It found patients had 30% increased odds of suffering a hip fracture within two months of taking a gabapentinoid medication.
Update of ‘leading handbook’ for diabetes support After four years and an evolving type 2 diabetes landscape, the RACGP has launched its refresh of the flagship clinical guideline.
In Practice: Member Engagement Survey reminder Members are encouraged to complete the 10-minute RACGP survey to ensure the issues that matter most to them are prioritised by the college.
Arthritis eLearning platform launched GPs interested in the latest evidence-based care recommendations for arthritis can now access free self-paced learning modules.
RACGP celebrates practice managers at national conference The college used the event to ‘listen, discuss, and share’, highlighting the importance of the profession and learning what it needs.
Is it time to trade in BMI for body roundness? GPs need to move away from using BMI as a diagnostic tool, one expert in the field says. So how should patients’ weight risks be calculated?